Patent details

Basic Information

Publication number:

EP3189135

PCT Application Number:

US2015048741

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP158382630

PCT Publication Number:

WO2016037159

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

RETINAL GANGLION CELLS AND PROGENITORS THEREOF

French Title of Invention:

CELLULES GANGLIONNAIRES DE LA RÉTINE ET LEURS PROGÉNITRICES

German Title of Invention:

RETINALE GANGLIENZELLEN UND VORLÄUFER DAFÜR

SPC Number:

Dates

Filing date:

05/09/2015

Grant date:

02/06/2021

EP Publication Date:

12/07/2017

PCT Publication Date:

10/03/2016

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

02/06/2021

EP B1 Publication Date:

02/06/2021

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

05/09/2021

Expiration date:

05/09/2035

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

26/05/2021

 

 

Name:

Astellas Institute for Regenerative Medicine

Address:

9 Technology Drive, Westborough, MA 01581, United States (US)

Inventor

1

Name:

LANZA, Robert P.

Address:

United States (US)

2

Name:

LU, Shi-Jiang

Address:

United States (US)

3

Name:

WANG, Wei

Address:

United States (US)

Priority

Priority Number:

201462046165 P

Priority Date:

05/09/2014

Priority Country:

United States (US)

Classification

IPC classification:

C12N 5/0793; C12N 5/0797; A61K 35/30; A61P 27/02;

Publication

European Patent Bulletin

Issue number:

202122

Publication date:

02/06/2021

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages